Looking to the future

Research designs for study of headache disease progression

Richard B. Lipton, Marcelo E. Bigal

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Evidence from clinical observation and population studies suggests that migraine sometimes transforms into chronic migraine. Risk factors for progression include headache frequency, obesity, snoring, stressful life events, and head injury. Other candidate risk factors include depression, anxiety, and lifestyle factors. Progression in a subgroup only raises the possibility that risk factor management or other forms of treatment may prevent migraine progression. Herein, we consider the design of clinical trials for interventions which could prevent the transformation of migraine to chronic migraine. We recommend enrolling individuals at high risk for progression based on baseline high headache frequency, delivering intervention in the context of a double-blind randomized trial and assessing either the onset of chronic migraine or major change in headache frequency as outcomes.

Original languageEnglish (US)
Pages (from-to)58-66
Number of pages9
JournalHeadache
Volume48
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Migraine Disorders
Headache
Disease Progression
Research Design
Snoring
Risk Management
Craniocerebral Trauma
Life Style
Anxiety
Obesity
Observation
Clinical Trials
Depression
Population

Keywords

  • Clinical trial
  • Disease modification
  • Migriane progression

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Looking to the future : Research designs for study of headache disease progression. / Lipton, Richard B.; Bigal, Marcelo E.

In: Headache, Vol. 48, No. 1, 01.2008, p. 58-66.

Research output: Contribution to journalArticle

@article{07cca4c58c6a47ee905052720fdebaf2,
title = "Looking to the future: Research designs for study of headache disease progression",
abstract = "Evidence from clinical observation and population studies suggests that migraine sometimes transforms into chronic migraine. Risk factors for progression include headache frequency, obesity, snoring, stressful life events, and head injury. Other candidate risk factors include depression, anxiety, and lifestyle factors. Progression in a subgroup only raises the possibility that risk factor management or other forms of treatment may prevent migraine progression. Herein, we consider the design of clinical trials for interventions which could prevent the transformation of migraine to chronic migraine. We recommend enrolling individuals at high risk for progression based on baseline high headache frequency, delivering intervention in the context of a double-blind randomized trial and assessing either the onset of chronic migraine or major change in headache frequency as outcomes.",
keywords = "Clinical trial, Disease modification, Migriane progression",
author = "Lipton, {Richard B.} and Bigal, {Marcelo E.}",
year = "2008",
month = "1",
doi = "10.1111/j.1526-4610.2007.00976.x",
language = "English (US)",
volume = "48",
pages = "58--66",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Looking to the future

T2 - Research designs for study of headache disease progression

AU - Lipton, Richard B.

AU - Bigal, Marcelo E.

PY - 2008/1

Y1 - 2008/1

N2 - Evidence from clinical observation and population studies suggests that migraine sometimes transforms into chronic migraine. Risk factors for progression include headache frequency, obesity, snoring, stressful life events, and head injury. Other candidate risk factors include depression, anxiety, and lifestyle factors. Progression in a subgroup only raises the possibility that risk factor management or other forms of treatment may prevent migraine progression. Herein, we consider the design of clinical trials for interventions which could prevent the transformation of migraine to chronic migraine. We recommend enrolling individuals at high risk for progression based on baseline high headache frequency, delivering intervention in the context of a double-blind randomized trial and assessing either the onset of chronic migraine or major change in headache frequency as outcomes.

AB - Evidence from clinical observation and population studies suggests that migraine sometimes transforms into chronic migraine. Risk factors for progression include headache frequency, obesity, snoring, stressful life events, and head injury. Other candidate risk factors include depression, anxiety, and lifestyle factors. Progression in a subgroup only raises the possibility that risk factor management or other forms of treatment may prevent migraine progression. Herein, we consider the design of clinical trials for interventions which could prevent the transformation of migraine to chronic migraine. We recommend enrolling individuals at high risk for progression based on baseline high headache frequency, delivering intervention in the context of a double-blind randomized trial and assessing either the onset of chronic migraine or major change in headache frequency as outcomes.

KW - Clinical trial

KW - Disease modification

KW - Migriane progression

UR - http://www.scopus.com/inward/record.url?scp=37549002532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549002532&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2007.00976.x

DO - 10.1111/j.1526-4610.2007.00976.x

M3 - Article

VL - 48

SP - 58

EP - 66

JO - Headache

JF - Headache

SN - 0017-8748

IS - 1

ER -